FDA全球物质注册数据库（FDA Global Substance Registration System）
物质名称OZARLIMOGENE INTEPLASMID
异名/同义词DNA (RECOMBINANT PLASMID EXPRESSION VECTOR PAC/EMM55 STREPTOCOCCUS PYOGENES SEROTYPE M55 MODIFIED ANTIGEN EMM55-SPECIFYING CDNA PLUS 5'-HUMAN CYTOMEGALOVIRUS ENHANCER AND PROMOTER/MULTIPLE CLONING SITE AND 3'-SV40 POLYA SIGNAL SEQUENCE/F1 BACTERIOPHAGE ORIGIN OF REPLICATION/AMPR PROMOTER/SV40 PROMOTER/SV40 ORIGIN OF REPLICATION/NEOMYCIN-AND KANAMYCIN-RESISTANCE CODING SEQUENCE/HERPES SIMPLEX VIRUS THYMIDINE KINASE POLYA SIGNAL SEQUENCE/BACTERIAL ORIGIN OF REPLICATION)
OZARLIMOGENE INTEPLASMID
OZARLIMOGENE INTEPLASMID (A DNA PLASMID ENCODING STREPTOCOCCUS PYOGENES SEROTYPE M55 (EMM55) CELL SURFACE PROTEIN (VARIANT))
OZARLIMOGENE INTEPLASMID (INN)
CAS登记号2366304-08-5
物质唯一标识(Unique Ingredient Identifier)GQ1H6X5174
分子式
国际化合物标识(International Chemical Identifier,InChI)
SMILES
分子结构式
欧洲化学品管理局注册号(ECHA)
成分类型 / INGREDIENT SUBSTANCE
关联数据
    扩展资源
    ©2006-2026 Drugfuture->FDA Global Substance Registration System